EC 3.1.1.7 (acetylcholinesterase) inhibitor
|
CHEBI_38462 |
[An EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of enzyme acetylcholinesterase (EC 3.1.1.7), which helps breaking down of acetylcholine into choline and acetic acid.] |
neuronal cell body membrane
|
GO_0032809 |
[The plasma membrane of a neuron cell body - excludes the plasma membrane of cell projections such as axons and dendrites.] |
adenosine 3',5'-bisphosphate
|
CHEBI_37240 |
|
thioester
|
CHEBI_51277 |
[A compound of general formula RC(=O)SR'. Compare with thionoester, RC(=S)OR'.] |
secondary carboxamide
|
CHEBI_140325 |
[A carboxamide resulting from the formal condensation of a carboxylic acid with a primary amine; formula RC(=O)NHR(1).] |
CHRNB2
|
OGG_3000001141 |
|
Lorazepam
|
CHEBI_6539 |
|
anxiolytic drug
|
CHEBI_35474 |
[Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions.] |
Loratadine
|
CHEBI_6538 |
|
quinapril
|
CHEBI_8713 |
[A member of the class of isoquinolines that is (3S)-2-L-alanyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid in which the alpha-amino group of the alanyl residue has been substituted by a 1-ethoxycarbonyl-4-phenylbutan-2-yl group (the all-S isomer). A prodrug for quinaprilat (by hydrolysis of the ethyl ester to the corresponding carboxylic acid), it is used as an angiotensin-converting enzyme inhibitor (ACE inhibitor) used (generally as the hydrochloride salt) for the treatment of hypertension and congestive heart failure.] |
disease of mental health
|
DOID_150 |
[A disease that involves a psychological or behavioral pattern generally associated with subjective distress or disability that occurs in an individual, and which are not a part of normal development or culture.] |
HSPD1
|
OGG_3000003329 |
|
Decursin
|
CHEBI_4353 |
|
population based study design
|
OMIABIS_0001022 |
[A study design that is multidisciplinary done at the population level or among the population groups, generally to find the cause, incidence or spread of the disease or to see the response to the treatment, nutrition or environment.] |
heterocyclic compound
|
CHEBI_5686 |
[A cyclic compound having as ring members atoms of at least two different elements.] |
NLRC4
|
OGG_3000058484 |
|
vitamin B6
|
CHEBI_27306 |
[Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).] |
Protein Family
|
NCIT_C20130 |
[Collection of proteins that are evolutionarily related. This is reflected in the structural and functional similarities as well as in the extent of sequence conservation or residue identity. (from SCOP)] |
acetyl-CoA
|
CHEBI_15351 |
[An acyl-CoA having acetyl as its S-acetyl component.] |
VAMP2
|
OGG_3000006844 |
|